German firm Boehringer Ingelheim’s patent for asthma drug revoked

India's Patent Office has revoked a patent on asthma drug, Spiriva held by German major Boehringer Ingelheim on an opposition filed by generic company, Cipla.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news